Essex Bio-Technology (HK:1061) has released an update.
Essex Bio-Technology shareholders showed strong confidence at the Annual General Meeting held on May 28, 2024, passing all proposed resolutions with overwhelming majority votes. Key resolutions included the re-election of board directors, the appointment of auditors, and the approval of a final dividend of HK$0.045 per share for the year ended December 31, 2023. The board was also granted mandates to manage share allotments and repurchases, reinforcing their authority to steer the company’s financial strategies.
For further insights into HK:1061 stock, check out TipRanks’ Stock Analysis page.
